Age (years) |
Mean | 65±11.11 |
Range | 35–88 |
|
Sex |
Male | 67 (58.3%) |
Female | 48 (41.7%) |
|
Management |
Diet only | 31 (27%) |
Tablets | 64 (55.7%) |
Insulin | 20 (17.4%) |
|
Home testing | 47 (40.9%) |
|
Strips/month (users) | 30.8±41.24 |
|
Time diagnosed (years) | 5.87±6.01 |
|
Comorbidity |
Vascular disease | 33 (28.7%) |
Hypertension | 41 (35.7%) |
On β-blockers | 32 (27.8%) |
On ACE inhibitors | 51 (44.3%) |
On statins | 53 (46.1%) |
|
Blood glucose |
HbA1C, average 2 years (range) | 7.93±1.42 (5.6–12.2) |
HbA1C, last (range) | 8.04±1.54 (5.8–13.2) |
|
Fasting/random blood glucose |
Fasting | 78 (67.8%) |
Random | 37 (32.2%) |